SCLEROMAX AS
Operating
Konsulenttjenester innen medisin, biomedisins forskning og
patentering, redaktørvirksomhet og artikkelforfatterskap,
samt handel og investering i næringsvirksomhet, herunder aksjer og
andeler og deltagelse i andre selskaper med lignende virksomhet.
Konsulenttjenester innen medisin, biomedisins forskning og
patentering, redaktørvirksomhet og artikkelforfatterskap, samt handel
og investering i næringsvirksomhet, herunder aksjer og andeler og
deltagelse i andre selskaper med lignende virksomhet.
Organization
- CEO
- AO
- Chairman of the board
- AO
- Years since formation
- 5 years
- since Dec 14, 2021
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 30,000
- 1 share class
- Total number of shareholders
- 1
- person
Financials
- Annual total result 2025
- -28,653
- NOK
- Total equity 2025
- -92,241
- NOK
Last update: Feb 23, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
AO | Managing Director/CEO | 100 % directly |
Board
| Name | Role | Shares |
|---|---|---|
AO | Chairman | 100 % directly |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
AO | Managing Director/CEO, Chairman | 100 % directly |
Last update: Aug 26, 2025
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
AO | Ordinary shares | 30,000 | 100 % |
Last update: Sep 25, 2026
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 |
Annual Total Result | -28,653 | -31,677 | -26,841 | -29,500 |
Total assets | 2,259 | 1,487 | 4,885 | 2,680 |
Total liabilities | 94,500 | 65,075 | 36,797 | 7,750 |
Total equity | -92,241 | -63,588 | -31,912 | -5,070 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 |
Total operating costs | 28,654 | 31,454 | 26,842 | 29,494 |
Operating result | -28,654 | -31,454 | -26,842 | -29,494 |
Financial income/costs | 1 | -223 | 0 | -6 |
Profit before tax | -28,653 | -31,677 | -26,841 | -29,500 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 |
Annual Total Result | -28,653 | -31,677 | -26,841 | -29,500 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total fixed assets | 0 | 0 | 0 | 0 |
Total current assets | 2,259 | 1,487 | 4,885 | 2,680 |
Total assets | 2,259 | 1,487 | 4,885 | 2,680 |
Short term debt | 94,500 | 65,075 | 36,797 | 7,750 |
Long term debt | 0 | 0 | 0 | 0 |
Total liabilities | 94,500 | 65,075 | 36,797 | 7,750 |
Contributed capital | 30,000 | 30,000 | 30,000 | 30,000 |
Retained earnings | -122,241 | -93,588 | -61,912 | -35,070 |
Total equity | -92,241 | -63,588 | -31,912 | -5,070 |
Total equity and liabilities | 2,259 | 1,487 | 4,885 | 2,680 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification